Skip to main content

Table 3 Results of cost-utility analysis

From: An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany

  Cost, € ∆ cost € Life years gained ∆ LYG QALYs gained ∆ QALY ICER, €/QALY
BAT 50,856 [34,358-59,437] 33,185 [24,561-38,637] 7.25 [3.44–9.17] 1.78 [0.45–2.71] 4.86 [2.30–6.14] 1.19 [0.30–1.81] 27,951 [21,357-82,970]
OMM 17,671 [9796-20,800] 5.47 [3.00–6.46] 3.67 [2.00–4.33]